Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism

American Journal of Cardiology

Volumn 97, Issue 1, 2006, Pages 127-129

  Fiumara, Karen ^a   Kucher, Nils ^a   Fanikos, John ^a   Goldhaber, Samuel Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTINEOPLASTIC AGENT; CATECHOLAMINE;

ACUTE DISEASE; ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SAFETY; EPISTAXIS; FEMALE; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HEMATURIA; HEMOPTYSIS; HOSPITAL; HUMAN; HYPERTENSION; HYPOTENSION; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MUSCLE HEMATOMA; PREDICTION; PRIORITY JOURNAL; RETROPERITONEAL HEMORRHAGE; RISK ASSESSMENT; SPLEEN HEMATOMA; SUBCUTANEOUS HEMORRHAGE;

DIABETES COMPLICATIONS; FEMALE; FIBRINOLYTIC AGENTS; HEMODYNAMIC PROCESSES; HEMORRHAGE; HUMANS; INFUSIONS, INTRAVENOUS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PULMONARY EMBOLISM; RISK FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 29244448969     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.07.117     Document Type: Article

References (12)

1. S.Z. Goldhaber, W.D. Haire, M.L. Feldstein, M. Miller, R. Toltzis, J.L. Smith, A.M. Taveira da Silva, P.C. Come, R.T. Lee, J.A. Parker Alteplase versus heparin in acute pulmonary embolism randomized trial assessing right-ventricular functional and pulmonary perfusion Lancet 341 1993 507 511
2. S. Konstantinides, A. Geibel, G. Heusel, F. Heinrich, W. Kasper Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism N Engl J Med 347 2002 1143 1150
3. S.Z. Goldhaber A contemporary approach to thrombolytic therapy for pulmonary embolism Vasc Med 5 2000 115 123
4. P.D. Stein, R.D. Hull, G. Raskob Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism Ann Intern Med 121 1994 313 317
5. D.S. Kanter, K.M. Mikkola, S.R. Patel, J.A. Parker, S.Z. Goldhaber Thrombolytic therapy for pulmonary embolism Frequency of intracranial hemorrhage and associated risk factors Chest 111 1997 1241 1245
6. K.M. Mikkola, S.R. Patel, J.A. Parker, F. Grodstein, S.Z. Goldhaber Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis Am Heart J 134 1997 69 72
7. G. Meyer, M. Gisselbrecht, J.L. Diehl, D. Journois, H. Sors Incidence and predictors of major hemorrhagic complications from thrombolytic therapy in patients with massive pulmonary embolism Am J Med 105 1998 472 477
8. C.S. Landefeld, P.A. Anderson, L.T. Goodnough, T.W. Moir, D.L. Hom, M.W. Rosenblatt, L. Goldman The bleeding severity index validation and comparison to other methods for classifying bleeding complications of medical therapy J Clin Epidemiol 42 1989 711 718
9. S. Wan, D.J. Quinlan, G. Agnelli, J.W. Eikelboom Thrombolysis compared with heparin for the initial treatment of pulmonary embolism a meta-analysis of the randomized controlled trials Circulation 110 2004 744 749
10. S.Z. Goldhaber, L. Visani, M. De Rosa Acute pulmonary embolism clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet 353 1999 1386 1389
11. L. Aklog, C.S. Williams, J.G. Byrne, S.Z. Goldhaber Acute pulmonary embolectomy a contemporary approach Circulation 105 2002 1416 1419
12. N. Kucher, S.Z. Goldhaber Management of massive pulmonary embolism Circulation 112 2005 e28 e32